Contact Levi & Korsinsky by March 10, 2025 Deadline to Join Class Action Against Regeneron Pharmaceuticals, Inc.(REGN)
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for potential securities law violations. Investors who suffered losses have until March 10, 2025, to join the lawsuit.
March 04, 2025 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for potential securities law violations. Investors have until March 10, 2025, to join the lawsuit, which could impact the company's stock price.
The announcement of a class action lawsuit against Regeneron Pharmaceuticals for potential securities law violations is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues can create uncertainty and potential financial liabilities for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100